GHP Investment Advisors Inc. Sells 4,860 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

GHP Investment Advisors Inc. lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 75.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,584 shares of the medical instruments supplier’s stock after selling 4,860 shares during the quarter. GHP Investment Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $39,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in XRAY. Nuance Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 3.8% during the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after purchasing an additional 402,329 shares during the last quarter. Qsemble Capital Management LP boosted its position in DENTSPLY SIRONA by 30.3% during the second quarter. Qsemble Capital Management LP now owns 21,647 shares of the medical instruments supplier’s stock valued at $539,000 after buying an additional 5,036 shares during the period. American Century Companies Inc. grew its stake in shares of DENTSPLY SIRONA by 7.8% during the second quarter. American Century Companies Inc. now owns 2,482,953 shares of the medical instruments supplier’s stock valued at $61,850,000 after buying an additional 179,119 shares during the last quarter. Texas Permanent School Fund Corp increased its holdings in shares of DENTSPLY SIRONA by 262.1% in the second quarter. Texas Permanent School Fund Corp now owns 158,572 shares of the medical instruments supplier’s stock worth $3,950,000 after buying an additional 114,779 shares during the period. Finally, United Services Automobile Association bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $379,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Barrington Research restated an “outperform” rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Needham & Company LLC restated a “buy” rating and issued a $34.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Evercore ISI lowered their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Finally, Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $33.44.

DENTSPLY SIRONA Trading Up 3.5 %

Shares of XRAY opened at $26.28 on Monday. DENTSPLY SIRONA Inc. has a 1-year low of $23.58 and a 1-year high of $37.60. The firm has a market capitalization of $5.33 billion, a price-to-earnings ratio of -59.73, a PEG ratio of 1.22 and a beta of 1.00. The firm’s 50-day moving average price is $25.40 and its 200-day moving average price is $28.09. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. During the same period in the previous year, the firm posted $0.51 earnings per share. The business’s revenue was down 4.3% compared to the same quarter last year. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.44%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.